A Sweet Approach to Heat Up Cancer Response to Immunotherapy
- PMID: 33262181
- DOI: 10.1158/2159-8290.CD-20-1355
A Sweet Approach to Heat Up Cancer Response to Immunotherapy
Abstract
Song and colleagues describe how N-glycans stabilize expression of checkpoint molecule B7-H4 that suppresses T-cell function. Inhibiting N-glycan stabilization of B7-H4 generates an immune hot cancer that is more responsive to combination therapies.See related article by Song et al., p. 1872.
©2020 American Association for Cancer Research.
Comment on
-
Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.Cancer Discov. 2020 Dec;10(12):1872-1893. doi: 10.1158/2159-8290.CD-20-0402. Epub 2020 Sep 16. Cancer Discov. 2020. PMID: 32938586 Free PMC article.
References
-
- Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10.
-
- Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321–30.
-
- Kather JN, Suarez-Carmona M, Charoentong P, Weis CA, Hirsch D, Bankhead P, et al. Topography of cancer-associated immune cells in human solid tumors. Elife. 2018;7:e36967.
-
- Song X, Zhou Z, Li H, Xue Y, Lu X, Bahar I, et al. Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers. Cancer Discov. 2020;10:1872–93.
-
- Ni L, Dong C. New B7 family checkpoints in human cancers. Mol Cancer Ther. 2017;16:1203–11.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
